DIAZEPAM AS AN ANTI-CONVULSANT AGENT IN ECT
Abstract
Evaluation of the scales on severity of convulsions revealed a significant difference between anectine-Na pentothal on the one hand and diazepam and placebo on the other hand. Even with the highest doses of diazepam, the convulsions were as severe as with placebo while they were significantly reduced on anectine-Na pentothal. This result is confirmed by the findings of fractures following diazepam and placebo, but not following anectine-Na pentothal. There were no side effects with anectine-Na pentothal treatment, but there was ataxia and drowsiness with high doses of diazepam.
It is concluded from this study that oral diazepam is not an adequate substitute for anectine-Na pentothal as pre-ECT medication for the prevention of fractures.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
